Edap Tms (EDAP) Competitors

Sanara MedTech (NASDAQ:SMTI) and Edap Tms (NASDAQ:EDAP) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk, community ranking and institutional ownership.

Do analysts recommend SMTI or EDAP?

Sanara MedTech currently has a consensus price target of $49.50, indicating a potential upside of 59.57%. Edap Tms has a consensus price target of $8.50, indicating a potential upside of 388.51%. Given Edap Tms' higher possible upside, analysts plainly believe Edap Tms is more favorable than Sanara MedTech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanara MedTech	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Edap Tms	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Which has better earnings and valuation, SMTI or EDAP?

Sanara MedTech has higher revenue and earnings than Edap Tms. Sanara MedTech is trading at a lower price-to-earnings ratio than Edap Tms, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanara MedTech	$86.67M	3.18	-$4.30M	-$1.34	-23.15
Edap Tms	$64.12M	1.01	-$22.92M	-$0.62	-2.81

Is SMTI or EDAP more profitable?

Sanara MedTech has a net margin of -10.71% compared to Edap Tms' net margin of -34.92%. Sanara MedTech's return on equity of -19.86% beat Edap Tms' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanara MedTech	-10.71%	-19.86%	-10.91%
Edap Tms	-34.92%	-44.21%	-25.88%

Do institutionals and insiders have more ownership in SMTI or EDAP?

8.1% of Sanara MedTech shares are owned by institutional investors. Comparatively, 62.7% of Edap Tms shares are owned by institutional investors. 54.1% of Sanara MedTech shares are owned by company insiders. Comparatively, 0.2% of Edap Tms shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the media favor SMTI or EDAP?

In the previous week, Sanara MedTech had 1 more articles in the media than Edap Tms. MarketBeat recorded 21 mentions for Sanara MedTech and 20 mentions for Edap Tms. Sanara MedTech's average media sentiment score of 0.33 beat Edap Tms' score of -0.01 indicating that Sanara MedTech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sanara MedTech	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Edap Tms	2 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	5 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community favor SMTI or EDAP?

Edap Tms received 325 more outperform votes than Sanara MedTech when rated by MarketBeat users. However, 61.54% of users gave Sanara MedTech an outperform vote while only 60.38% of users gave Edap Tms an outperform vote.

Company	Underperform	Outperform
Sanara MedTech	Outperform Votes 24 61.54%	Underperform Votes 15 38.46%
Edap Tms	Outperform Votes 349 60.38%	Underperform Votes 229 39.62%

Which has more volatility and risk, SMTI or EDAP?

Sanara MedTech has a beta of 1.38, suggesting that its share price is 38% more volatile than the S&P 500. Comparatively, Edap Tms has a beta of 0.13, suggesting that its share price is 87% less volatile than the S&P 500.

Summary

Sanara MedTech beats Edap Tms on 13 of the 18 factors compared between the two stocks.